What Researchers Did
This systematic review evaluated the current clinical and mechanistic understanding of crush syndrome, its anatomical impact, and renal complications, with a focus on therapeutic interventions.
What They Found
The review included six studies, highlighting ischemia-reperfusion injury, rhabdomyolysis, and ferroptosis as key drivers of systemic toxicity, often culminating in acute kidney injury (AKI). Prolonged soft tissue compression and necrosis posed serious risks for long-term disability, and adjunctive therapies like hyperbaric oxygen therapy demonstrated potential benefits, though evidence was limited.
What This Means for Canadian Patients
Canadian patients experiencing crush injuries could benefit from early recognition and management of systemic toxicity, including acute kidney injury. Further research into standardized, evidence-based protocols and adjunctive therapies may improve outcomes for these patients.
Canadian Relevance
This systematic review does not have a direct Canadian connection.
Study Limitations
The evidence for adjunctive therapies was limited by study heterogeneity.